Overview

Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of rebamipide ophthalmic suspension in subjects with dry eye syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
Acucela Inc.
Kubota Vision Inc.
Collaborator:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Rebamipide